$BXBL

BOXABL Inc.

CIK:0001906364|SEC Filings

Condensed Statements of Operations (Unaudited) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2026	Jun. 30, 2025	Jun. 30, 2026	Jun. 30, 2025
Operating expenses:
General and administrative expenses	$ 4,555,829	$ 83,539	$ 4,829,127	$ 210,395
Loss from operations	(4,555,829)	(83,539)	(4,829,127)	(210,395)
Other income & expenses:
Loss on initial recognition forward purchase agreement liability	(8,603,256)		(8,603,256)
Change in fair value of forward purchase agreement liability	(1,074,131)		(1,074,131)
Investment income on trust account	490,166	842,499	1,212,390	1,402,254
Income tax expense	(102,935)	(176,925)	(264,099)	(294,474)
Total other income	(9,290,156)	665,574	(8,729,096)	1,107,780
Net income (loss)	$ (13,845,985)	$ 582,035	$ (13,558,223)	$ 897,385
Common Stock Shares Subject To Possible Redemption [Member]
Other income & expenses:
Weighted average common shares outstanding basic	8,000,000	8,000,000	8,000,000	6,674,033
Basic income (loss) per share	$ (1.335)	$ 0.071	$ (1.287)	$ 0.207
Weighted average common shares outstanding diluted	8,000,000	8,800,000	8,000,000	7,341,436
Diluted income (loss) per share	$ (1.335)	$ 0.065	$ (1.287)	$ 0.186
Common Stock Shares Not Subject To Possible Redemption [Member]
Other income & expenses:
Weighted average common shares outstanding basic	2,295,800	2,295,800	2,295,800	2,308,098
Basic income (loss) per share	$ (1.378)	$ 0.005	$ (1.420)	$ (0.211)
Weighted average common shares outstanding diluted	2,295,800	2,325,380	2,295,800	2,332,776
Diluted income (loss) per share	$ (1.378)	$ 0.005	$ (1.420)	$ (0.199)

Condensed Statements of Cash Flows (Unaudited) - USD ($)	6 Months Ended
	Jun. 30, 2026	Jun. 30, 2025
Cash flows from operating activities
Net income (loss)	$ (13,558,223)	$ 897,385
Adjustments to reconcile net loss to net cash used in operating activities:
Interest earned on funds held in trust account	(1,212,390)
Loss on initial recognition of forward purchase agreement	8,603,256
Change in fair value of forward purchase agreement liability	1,074,131
Changes in operating assets and liabilities:
Deferred offering cost		(20,939)
Accounts payable	4,384,186	(21,716)
Prepaid expenses	44,928	(148,912)
Tax liability	264,099	294,474
Interest expense		6,671
Net cash provided by (used in) operating activities	(400,013)	1,006,963
Cash flows from investing activities
Investment into trust account		(81,628,583)
Net cash used in investing activities		(81,628,583)
Cash flows from financing activities
Proceeds from promissory note		417,000
Repayment of promissory note		(548,671)
Proceeds from sale of 8,000,000 units at $10 per unit in IPO net of offering cost paid at closing		78,641,719
Proceeds from sale of 248,300 units to Sponsor in private placement		2,483,000
Proceeds from sale of 40,000 units to underwriters in private placement		100
Proceeds from sale of 1,000,000 $15 strike warrants in private placement		100,000
Net cash provided by financing activities		81,093,148
Net increase in cash	(400,013)	471,528
Cash at beginning of period	486,900	46,285
Cash and cash equivalents at end of period	$ 86,887	$ 517,813

Condensed Balance Sheets (Unaudited) - USD ($)	Jun. 30, 2026	Dec. 31, 2025
Current assets
Cash and Cash Equivalents	$ 86,887	$ 486,900
Prepaid expenses	52,620	97,547
Total current assets	139,507	584,447
Cash and investments held in trust account	83,202,034	82,136,888
TOTAL ASSETS	83,341,541	82,721,335
Current liabilities
Accounts payable	4,441,357	57,171
Tax liability	254,602	137,747
Forward purchase agreement liability, at fair value	9,677,387
TOTAL CURRENT LIABILITIES	14,373,346	194,918
COMMITMENTS AND CONTINGENCIES
Common stock; $0.0001 par value, subject to possible redemption, 8,000,000 shares at redemption value	83,202,034	82,136,888
STOCKHOLDERS’ EQUITY (DEFICIT)
Preferred Stock, $0.0001 par value; 1,000,000 shares authorized; 0 issued and outstanding
Common stock, $0.0001 par value; 100,000,000 shares authorized; 2,295,800 issued and outstanding (excluding 8,000,000 shares subject to possible redemption)	259	259
Retained earnings (accumulated deficit)	(14,234,098)	389,270
Total Stockholders’ Equity (Deficit)	(14,233,839)	389,529
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT)	$ 83,341,541	$ 82,721,335